As 2024 winds down and the number of FDA-approved medical devices packing AI approaches 1,000—the agency had the tally at 950 as of August—the industry finds itself at a “critical inflection point.” 

Nurses tend to feel optimistic if not exactly excited about AI’s advances into their profession. Those who hold back tend to share a common concern—sacrificing care quality for the sake of tech-enabled efficiency. 

Generative AI is fixing to transform the pharmaceutical industry. However, not all adopters will reap rewards in comparable degrees.  

10 notable quotes about AI from the past 5 days.

In the rush to do something, anything with AI, are America’s business leaders playing fast and loose with the risks? 

A machine learning-powered smartphone app was trained to detect hundreds of biomarkers in the human voice, using even the tiniest detail to anticipate when patients may present with symptoms of hypertension. 

The AI advisory board of the United Nations is calling for the creation of a global AI data framework. 

If putting an AI plan in place were a team sport, the Payers would be outpacing the Providers quite handily.